Back to top
more

Evofem Biosciences (EVFM)

(Delayed Data from OTC)

$0.01 USD

0.01
667,905

0.00 (-3.00%)

Updated Aug 9, 2024 03:55 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (75 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Evofem Biosciences, Inc. [EVFM]

Reports for Purchase

Showing records 21 - 40 ( 118 total )

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 21

04/24/2020

Company Report

Pages: 4

Dropping Coverage

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 22

04/17/2020

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 23

04/16/2020

Company Report

Pages: 8

Tackling the Bear: Why Phexxi is More than Just Another Contraceptive Gel

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 24

03/20/2020

Industry Report

Pages: 9

Yas'' Weekly Recap of Our Key Notes and 16 Doc Calls Upcoming in 1H20

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 25

03/16/2020

Company Report

Pages: 4

2019 Financial Results; Looking Ahead to Launch; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 26

03/13/2020

Industry Report

Pages: 4

Yas'' Weekly Recap of Our Key Notes and 19 Doc Calls Upcoming in 1H20

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 27

03/13/2020

Daily Note

Pages: 8

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 28

03/13/2020

Company Report

Pages: 8

4Q19 - Shaking Up the Contraceptive Market in 2020: Make Way for Phexxi

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 29

03/10/2020

Industry Report

Pages: 6

18 Doc Calls Across 8 Therapeutic Areas Upcoming in 1H20

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 30

02/28/2020

Industry Report

Pages: 6

Two Women''s Health Companies to See - Why at Our 32nd Conference

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 31

02/28/2020

Industry Report

Pages: 4

Yas'' Weekly Recap of Our Key Notes and 8 Doc Calls Upcoming in 1H20

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 32

02/28/2020

Company Report

Pages: 8

Takeaways from Our Contraception Pricing Call with David Katz

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 33

02/27/2020

Company Report

Pages: 7

Dial-in to Today''s Call on Contraception Pricing at 12pm ET

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 34

02/26/2020

Daily Note

Pages: 6

2 Must-Dial In Calls This Week

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 35

02/24/2020

Daily Note

Pages: 6

3 Must-Dial In Calls This Week

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 36

02/21/2020

Industry Report

Pages: 8

Yas Weekly Recap of Our Key Notes and 9 Doc Calls Upcoming in 1H20

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 37

02/18/2020

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 38

02/14/2020

Company Report

Pages: 7

Join Part 1 of our Women''s Health Call Series on Feb. 27 at 12pm

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 39

02/14/2020

Industry Report

Pages: 7

Yas'' Weekly Recap of Our Key Notes and 10 Doc Calls Upcoming in 1H20

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Evofem Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 40

02/07/2020

Daily Note

Pages: 9

Yas'' Weekly Recap of Our Key Notes and 11 Doc Calls Upcoming in 1H20

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party
// eof